Clinical trial
Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection
NCT02648009 is registered in ClinicalTrials.gov with Sunnybrook Health Sciences Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection
- Lead sponsor
- Sunnybrook Health Sciences Centre
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- April 30, 2016
- Completion date
- April 30, 2027
- Enrollment
- 112 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.